We are live on ! Find out more
WAS

WESPAC Advisors SoCal Portfolio holdings

AUM $560M
1-Year Est. Return 37.11%
This Fund
S&P 500
This Quarter Est. Return
+21.38%
1 Year Est. Return
+37.11%
3 Year Est. Return
+127.08%
5 Year Est. Return
+158.7%
10 Year Est. Return
+511.4%
AUM
$216M
AUM Growth
+$35.5M
Cap. Flow
+$17.4M
Cap. Flow %
8.06%
Top 10 Hldgs %
43.63%
Holding
89
New
10
Increased
38
Reduced
22
Closed
10

Sector Composition

Rank Sector Weight
1 Technology 27.57%
2 Healthcare 15.98%
3 Industrials 11.21%
4 Communication Services 11.16%
5 Consumer Discretionary 8.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GS icon
51
Goldman Sachs
GS
$309B
$585K 0.27%
2,846
IYC icon
52
iShares US Consumer Discretionary ETF
IYC
$1.14B
$514K 0.24%
9,000
+1,840
+26% +$95.2K
FBT icon
53
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.8B
$492K 0.23%
2,840
+465
+20% +$73K
CHD icon
54
Church & Dwight Co
CHD
$23.4B
$453K 0.21%
5,475
-1,300
-19% -$94.6K
GDX icon
55
VanEck Gold Miners ETF
GDX
$23.2B
$433K 0.2%
11,265
LH icon
56
Labcorp
LH
$24.7B
$427K 0.2%
2,881
-844
-23% -$117K
IHI icon
57
iShares US Medical Devices ETF
IHI
$3.06B
$419K 0.19%
9,330
+2,010
+27% +$85.9K
QQQ icon
58
Invesco QQQ Trust
QQQ
$449B
$393K 0.18%
1,489
-3
-0.2% -$672
ITA icon
59
iShares US Aerospace & Defense ETF
ITA
$14.4B
$383K 0.18%
4,840
+1,170
+32% +$92.3K
TSM icon
60
TSMC
TSM
$2.07T
$369K 0.17%
5,775
+575
+11% +$30.3K
NBIX icon
61
Neurocrine Biosciences
NBIX
$17.7B
$320K 0.15%
2,465
GNW icon
62
Genworth Financial
GNW
$3.79B
$314K 0.15%
150,000
+125,000
+500% +$393K
ILMN icon
63
Illumina
ILMN
$28.7B
$307K 0.14%
853
SAP icon
64
SAP
SAP
$200B
$295K 0.14%
1,925
-10
-0.5% -$1.23K
TTC icon
65
Toro Company
TTC
$9.01B
$276K 0.13%
4,275
-6,030
-59% -$396K
GIB icon
66
CGI
GIB
$14.5B
$274K 0.13%
4,300
C icon
67
Citigroup
C
$223B
$261K 0.12%
4,953
EL icon
68
Estee Lauder
EL
$30.1B
$259K 0.12%
1,365
BP icon
69
BP
BP
$109B
$247K 0.11%
10,996
-401
-4% -$9.63K
APH icon
70
Amphenol
APH
$184B
$232K 0.11%
9,780
-12,780
-57% -$285K
CBOE icon
71
Cboe Global Markets
CBOE
$30.2B
$231K 0.11%
2,520
-15
-0.6% -$1.48K
MAR icon
72
Marriott International
MAR
$101B
$230K 0.11%
+2,600
New +$226K
CP icon
73
Canadian Pacific Kansas City
CP
$81.1B
$219K 0.1%
+4,250
New +$202K
IWF icon
74
iShares Russell 1000 Growth ETF
IWF
$120B
$205K 0.09%
+4,060
New +$179K
EW icon
75
Edwards Lifesciences
EW
$47.8B
$203K 0.09%
3,000

Similar funds

WESPAC Advisors SoCal's Q2 2020 Portfolio in Review

As of Q2 2020, WESPAC Advisors SoCal held 89 positions worth $216M, up 20% from $180M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

WESPAC Advisors SoCal deployed $17.4M of net new capital in Q2 2020, opening 10 new positions and adding to 38 existing holdings. Its largest new stake was Chevron: 63,314 shares worth $5.4M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Costco, an estimated $3.81M trimmed.

  • WESPAC Advisors SoCal's largest Q2 2020 buy was Chevron: 63,314 shares worth $5.4M.
  • WESPAC Advisors SoCal added most to East-West Bancorp in Q2 2020, an estimated $668K increase.
  • WESPAC Advisors SoCal's biggest Q2 2020 reduction was Costco, cutting an estimated $3.81M.
  • WESPAC Advisors SoCal fully exited Berkshire Hathaway Class B in Q2 2020, selling an estimated $814K.
  • WESPAC Advisors SoCal's ten largest holdings make up 44% of its $216M portfolio in Q2 2020.
  • WESPAC Advisors SoCal opened 10 new positions and closed 10 in Q2 2020.
  • WESPAC Advisors SoCal's portfolio value rose 20% quarter-over-quarter to $216M.

Based on WESPAC Advisors SoCal's 13F filing for Q2 2020, filed 17 Jul 2020.